AstraZeneca Faces Difficult Questions About Its Vaccine After Admitting Mistake

Some trial participants only got a partial dose of AstraZeneca ’s vaccine. Experts said the company’s spotty disclosures have eroded confidence.

Source: NYT Health - November 25, 2020 Category: Consumer Health News Authors: Rebecca Robbins and Benjamin Mueller Tags: Coronavirus (2019-nCoV) Vaccination and Immunization Clinical Trials AstraZeneca PLC Oxford University Source Type: news